Advertisement

Advertisement

2018 ASH Annual Meeting

Advertisement

Advertisement



Nov
17
Today In Oncology
Incidence of Head and Neck Melanoma in North American Youth
Targeted Triplet Therapy Improved Overall Survival in BRAF-Mutated Colorectal Cancer
Maximizing Benefit in the Treatment of Immune-Mediated Colitis
First-Line Nivolumab/Ipilimumab in Special Populations With NSCLC
FDA Grants Accelerated Approval to Zanubrutinib for Pretreated Mantle Cell Lymphoma
View More 
Advertisement
Most Read Stories
Dietary Fiber, Yogurt Consumption, and Lung Cancer Risk
Management of HER2-Positive Breast Cancer: Business as Usual?
2019 NCRI: CA125 Testing May Help General Practitioners to Detect Ovarian Cancer
Lenalidomide vs Observation in Asymptomatic Smoldering Multiple Myeloma
Management of Locally Advanced Pancreatic Cancer: A Call for Action
View More 
Most Viewed Videos
Elizabeth A. Mittendorf, MD, PhD, on Breast Cancer Immunotherapy: Building on Recent Successes
Ana Maria Arance Fernandez, MD, PhD, on Advanced Melanoma: Treatment With Cobimetinib/Atezolizumab vs Pembrolizumab
Bernardo H.L. Goulart, MD, on Stage IV NSCLC: High Drug Costs May Affect Survival
Sherene Loi, MD, PhD, and Leisha A. Emens, MD, PhD, on HER2-Positive Breast Cancer: KATE2 Study of Atezolizumab/Trastuzumab Emtansine
Jeffrey A. Meyerhardt, MD, MPH, on Colon Cancer: Results From the ACTS-CC 02 Trial on Adjuvant Chemotherapy
View More 
© 2019 HSP News Service, L.L.C.